CNBC's Jim Cramer Stands Behind Elon Musk's Decision to Use Ketamine for Depression
CNBC's Jim Cramer Stands Behind Elon Musk's Use of Ketamine for Depression
In a recent interview, CNBC's Jim Cramer voiced his support for Elon Musk's decision to disclose his use of prescription ketamine in treating his depression. According to Cramer, Musk's openness about his mental health challenges is commendable, as it may inspire others to seek help without fear.
The Positive Impact of Openness and Transparency
Jim Cramer emphasized that Musk's revelation could potentially save lives by encouraging individuals to address their mental health concerns proactively. By destigmatizing mental health treatments through his actions, Musk sets a precedent for open dialogue and acceptance in the corporate world.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.